Ad is loading...
HAE
Price
$83.03
Change
+$1.84 (+2.27%)
Updated
Dec 9, 04:59 PM (EDT)
64 days until earnings call
ICAD
Price
$1.88
Change
+$0.14 (+8.05%)
Updated
Dec 9, 04:59 PM (EDT)
79 days until earnings call
Ad is loading...

HAE vs ICAD

Header iconHAE vs ICAD Comparison
Open Charts HAE vs ICADBanner chart's image
Haemonetics
Price$83.03
Change+$1.84 (+2.27%)
Volume$3.29K
CapitalizationN/A
iCAD
Price$1.88
Change+$0.14 (+8.05%)
Volume$4.44K
CapitalizationN/A
HAE vs ICAD Comparison Chart
Loading...
HAE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ICAD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
HAE vs. ICAD commentary
Dec 10, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HAE is a Hold and ICAD is a Hold.

COMPARISON
Comparison
Dec 10, 2024
Stock price -- (HAE: $81.19 vs. ICAD: $1.74)
Brand notoriety: HAE and ICAD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: HAE: 89% vs. ICAD: 73%
Market capitalization -- HAE: $4.33B vs. ICAD: $42.43M
HAE [@Medical Specialties] is valued at $4.33B. ICAD’s [@Medical Specialties] market capitalization is $42.43M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HAE’s FA Score shows that 0 FA rating(s) are green whileICAD’s FA Score has 0 green FA rating(s).

  • HAE’s FA Score: 0 green, 5 red.
  • ICAD’s FA Score: 0 green, 5 red.
According to our system of comparison, ICAD is a better buy in the long-term than HAE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HAE’s TA Score shows that 5 TA indicator(s) are bullish while ICAD’s TA Score has 4 bullish TA indicator(s).

  • HAE’s TA Score: 5 bullish, 5 bearish.
  • ICAD’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, HAE is a better buy in the short-term than ICAD.

Price Growth

HAE (@Medical Specialties) experienced а -7.18% price change this week, while ICAD (@Medical Specialties) price change was +0.58% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.10%. For the same industry, the average monthly price growth was +0.05%, and the average quarterly price growth was +0.14%.

Reported Earning Dates

HAE is expected to report earnings on Feb 11, 2025.

ICAD is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Medical Specialties (-1.10% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HAE($4.34B) has a higher market cap than ICAD($42.4M). ICAD YTD gains are higher at: -1.695 vs. HAE (-5.052). HAE has higher annual earnings (EBITDA): 264M vs. ICAD (-12.18M). HAE has more cash in the bank: 194M vs. ICAD (19M). ICAD has less debt than HAE: ICAD (514K) vs HAE (871M). HAE has higher revenues than ICAD: HAE (1.27B) vs ICAD (25.4M).
HAEICADHAE / ICAD
Capitalization4.34B42.4M10,224%
EBITDA264M-12.18M-2,168%
Gain YTD-5.052-1.695298%
P/E Ratio34.47N/A-
Revenue1.27B25.4M5,000%
Total Cash194M19M1,021%
Total Debt871M514K169,455%
FUNDAMENTALS RATINGS
HAE vs ICAD: Fundamental Ratings
HAE
ICAD
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
34
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
5892
PRICE GROWTH RATING
1..100
5249
P/E GROWTH RATING
1..100
45100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ICAD's Valuation (34) in the Computer Peripherals industry is somewhat better than the same rating for HAE (74) in the Medical Specialties industry. This means that ICAD’s stock grew somewhat faster than HAE’s over the last 12 months.

ICAD's Profit vs Risk Rating (100) in the Computer Peripherals industry is in the same range as HAE (100) in the Medical Specialties industry. This means that ICAD’s stock grew similarly to HAE’s over the last 12 months.

HAE's SMR Rating (58) in the Medical Specialties industry is somewhat better than the same rating for ICAD (92) in the Computer Peripherals industry. This means that HAE’s stock grew somewhat faster than ICAD’s over the last 12 months.

ICAD's Price Growth Rating (49) in the Computer Peripherals industry is in the same range as HAE (52) in the Medical Specialties industry. This means that ICAD’s stock grew similarly to HAE’s over the last 12 months.

HAE's P/E Growth Rating (45) in the Medical Specialties industry is somewhat better than the same rating for ICAD (100) in the Computer Peripherals industry. This means that HAE’s stock grew somewhat faster than ICAD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HAEICAD
RSI
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
72%
Bullish Trend 4 days ago
83%
MACD
ODDS (%)
Bearish Trend 4 days ago
66%
Bearish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
66%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
65%
Bearish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 14 days ago
67%
Bullish Trend 13 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
63%
Bearish Trend 19 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
88%
Aroon
ODDS (%)
Bearish Trend 4 days ago
75%
Bullish Trend 4 days ago
79%
View a ticker or compare two or three
Ad is loading...
HAE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ICAD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVMI195.189.29
+5.00%
Nova Ltd
NRDY1.610.06
+3.87%
Nerdy
FTNT99.210.75
+0.76%
Fortinet
VCIG2.17-0.02
-0.91%
VCI Global Limited
FLNG21.93-0.71
-3.14%
FLEX LNG Ltd

HAE and

Correlation & Price change

A.I.dvisor indicates that over the last year, HAE has been loosely correlated with OM. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if HAE jumps, then OM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HAE
1D Price
Change %
HAE100%
+0.64%
OM - HAE
41%
Loosely correlated
+0.84%
GH - HAE
39%
Loosely correlated
-0.65%
CRL - HAE
33%
Poorly correlated
+0.14%
A - HAE
31%
Poorly correlated
+1.97%
BLFS - HAE
30%
Poorly correlated
+4.21%
More